Drugs.com: Escitalopram reduces symptoms of anxiety in teens
Outlet covers UC research that points to a possible new treatment for adolescent anxiety
For adolescents with generalized anxiety disorder, UC research has shown that the medication escitalopram could reduce symptoms. The study was published online Aug. 25 in The Journal of Clinical Psychiatry.
Jeffrey Strawn, MD, associate professor and anxiety expert in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati, and colleagues treated adolescents with anxiety disorder with escitalopram or a placebo for eight weeks to see if improvement occurred.
"For clinicians treating anxious adolescents, this study provides preliminary answers to important questions about the effectiveness of this treatment," Strawn says.
Read the full Drugs.com story.
Psych Central also reported on this research.
Read the full UC News release.
Featured photo courtesy of Unsplash.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Yahoo! News promotes UC botanist's solution for honeysuckle
February 10, 2026
Yahoo! News shared University of Cincinnati botanist Denis Conover's method for eliminating honeysuckle without using chemicals.
University of Cincinnati Cancer Center names David Gius, MD, PhD, as director
February 10, 2026
Following a highly competitive national search, the University of Cincinnati Cancer Center has appointed David Gius, MD, PhD, as its next director.
Breakthrough UC study sheds light on survival of new neurons in adult brain
February 9, 2026
Research from the University of Cincinnati College of Medicine, recently published in the journal Nature Communications, is revealing how immune cells in the adult brain regulate the generation of new neurons.